ARCHIVES

ASCO Survey Finds Practice Expenses 90% Higher Than Medicare Assumptions

This article is from The Cancer Letter archive.

Vol. 28 No. 37 | October 11, 2002

Download PDF Visit The Full Archive

Related Articles

FDA Approves Taxotere For Node+ Breast Cancer

August 27, 2004

Pfizer’s Inlyta Gives FDA a Teaching Moment: Not All PFS Advantages Are Created Equal

December 16, 2011

Niederhuber: Clinical Trials System Must Refocus To Emphasize Translational Studies.

July 9, 2010

Clearinghouse Finds Five Compounds Pose Risk To Humans

March 2, 1979

Clinical Trials Approved By NCI

October 31, 2003

PDQ Evaluation to Cost NCI More Than Reported

June 29, 1990